Einloggen
E-Mail
Passwort
Passwort anzeigen
Merken
Passwort vergessen?
Werden Sie kostenlos Mitglied
Registrieren
Registrieren
Mitglied werden
Kostenlos registrieren
Abonnent werden
Unser Angebot
Einstellungen
Einstellungen
Dynamische Kurse 
OFFON
  1. Startseite
  2. Aktien
  3. Deutschland
  4. Xetra
  5. Evotec SE
  6. News
  7. Andere Sprachen
    EVT   DE0005664809   566480

EVOTEC SE

(EVT)
  Bericht
ÜbersichtKurseChartsNewsRatingsTermineUnternehmenFinanzenAnalystenschätzungenRevisionenDerivate 
ÜbersichtAlle NewsAnalystenempfehlungenAndere SprachenPressemitteilungenOffizielle PublikationenBranchen-News
Nachrichten in anderen Sprachen über EVOTEC SE
11.10.PASITHEA THERAPEUTICS : Partners With Evotec for Drug Development Project
11.10.EVOTEC : expands neuroscience collaboration with Bristol Myers Squibb to include novel cel..
11.10.EVOTEC : LUMITOS AG - Evotec expands neuroscience collaboration with Bristol Myers Squibb ..
11.10.EVOTEC : Plans Offering, Secondary Listing Of American Depositary Shares
11.10.EVOTEC : files registration statement for proposed offering of American Depositary Shares
11.10.EVOTEC : files registration statement for proposed offering of American Depositary Shares
11.10.PRESS RELEASE : Evotec SE files registration statement for proposed offering of American D..
08.10.Evotec Files for Initial Public Offering in the U.S.
08.10.EVOTEC : To Study New Cell Types In $9 Million Collaboration With US Pharma Group
08.10.EVOTEC : expands neuroscience collaboration with Bristol Myers Squibb to include novel cel..
08.10.EVOTEC : expands neuroscience collaboration with Bristol Myers Squibb to include novel cel..
08.10.PRESS RELEASE : Evotec expands neuroscience collaboration with Bristol Myers Squibb to inc..
08.10.Evotec Expands Neuroscience Collaboration with Bristol Myers Squibb to Include Novel Ce..
08.10.Evotec SE has filed an IPO in the amount of $100 million.
30.09.EVOTEC SE : Release according to Article 41 of the WpHG [the German Securities Trading Act..
15.09.EVOTEC : publishes DDup 11 – AI-driven antibody discovery at Evotec
06.09.EVOTEC PARTNER BAYER : Phase IIb trial shows eliapixant significantly decreases cough freq..
02.09.KAZIA THERAPEUTICS : Evt801 phase i study receives full regulatory approval
02.09.EVOTEC : and Secarna Pharmaceuticals expand strategic partnership in the field of antisens..
02.09.PRESS RELEASE : Secarna Pharmaceuticals GmbH & Co. KG: Secarna Pharmaceuticals and Evotec ..
02.09.Secarna Pharmaceuticals and Evotec Expand Strategic Partnership in the Field of Antisen..
02.09.KAZIA THERAPEUTICS : Secures French Regulatory Approval for Phase 1 Trial of Cancer Inhibi..
02.09.EVOTEC : partner Kazia Therapeutics announces full regulatory approval for Phase I study o..
02.09.EVOTEC : announces Bristol Myers Squibb opt-in of EVT8683 as the first programme from iPSC..
02.09.EVOTEC : announces Bristol Myers Squibb opt-in of EVT8683 as the first programme from iPSC..
02.09.PRESS RELEASE : Evotec announces Bristol Myers -2-
02.09.PRESS RELEASE : Evotec announces Bristol Myers Squibb opt-in of EVT8683 as the first progr..
02.09.Evotec SE Announces Bristol Myers Squibb Opt-In of Evt8683 as the First Programme from ..
01.09.Evotec SE english
31.08.DGAP-NVR : Evotec SE: Release according to Article 41 of the WpHG [the German Securities T..
25.08.DGAP-PVR : Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German S..
18.08.Immunitas Therapeutics, Inc. announced that it has received $58 million in funding from..
12.08.EVOTEC : Analyst presentation
12.08.EVOTEC : Analystenpräsentation
12.08.EVOTEC : Just - Evotec Biologics opens J.POD 1 US in Redmond, Washington
11.08.Evotec Se Reports Earnings Results for the Second Quarter Ended June 30, 2021
11.08.EVOTEC : Präsentation (englisch)
11.08.EVOTEC : Just - Evotec Biologics opens J.POD® 1 US in Redmond, Washington
11.08.EVOTEC : reports first half-year 2021 results and corporate updates
11.08.EVOTEC : Just - Evotec Biologics opens J.POD 1 US in Redmond, Washington
11.08.PRESS RELEASE : Just - Evotec Biologics opens -2-
11.08.PRESS RELEASE : Just - Evotec Biologics opens J.POD 1 US in Redmond, Washington
11.08.EVOTEC : Reports first half-year 2021 results and corporate updates
11.08.PRESS RELEASE : Evotec se reports first half-year -2-
11.08.PRESS RELEASE : Evotec se reports first half-year 2021 results and corporate updates
11.08.Evotec SE Provides Revenue Guidance for the Full Year of 2021
10.08.Immunitas Therapeutics, Inc. announced that it expects to receive $57.660258 million in..
04.08.EVOTEC : Positive Phase IIb data for investigational P2X3 antagonist in patients with refr..
04.08.BAYER : investigational P2X3 antagonist meets primary efficacy endpoint and shows favorabl..
04.08.EVOTEC : to announce results for the first half-year 2021 on 11 August 2021
04.08.EVOTEC : to announce results for the first half-year 2021 on 11 August 2021
04.08.PRESS RELEASE : Evotec SE to announce results for the first half-year 2021 on 11 August 20..
03.08.EVOTEC SE : Positive Phase IIb data for investigational P2X3 antagonist in patients with r..
03.08.DGAP-ADHOC : Evotec SE: Positive Phase IIb data for investigational P2X3 antagonist in pat..
03.08.Evotec SE Announces Positive Phase IIb Data for Investigational P2X3 Antagonist in Pati..
02.08.EVOTEC : Submits Registration Statement For ADSs To US Securities Watchdog
02.08.EVOTEC : Announces Confidential Submission of Draft Registration Statement on Form F-1 wit..
02.08.DGAP-ADHOC : Evotec SE Announces Confidential Submission of Draft Registration Statement o..
30.07.EVOTEC SE : Release according to Article 41 of the WpHG [the German Securities Trading Act..
30.07.DGAP-NVR : Evotec SE: Release according to Article 41 of the WpHG [the German Securities T..
29.07.EVOTEC : spin-off Topas Therapeutics extends Series B, raising total of € 40 m (~ $ 48 m) ..
29.07.EVOTEC : spin-off Topas Therapeutics extends Series B, raising total of € 40 m (~$ 48 m) i..
29.07.EVOTEC : spin-off Topas Therapeutics extends Series B, raising total of €40 Million (~$48 ..
29.07.PRESS RELEASE : Topas Therapeutics Extends Series B, Raising Total of EUR40 Million (USD 4..
26.07.EVOTEC SE : Release according to Article 40, Section 1 of the WpHG [the German Securities ..
26.07.DGAP-PVR : Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German S..
19.07.SMALL CAPS : les derniers choix des stars de la gestion
06.07.Oxford Cannabinoid Technologies Signs Deal for Phase 1 Trials
02.07.EVOTEC : creates long-term growth opportunities by initiating 'Campus Levi-Montalcini' in ..
02.07.EVOTEC : Germany's Evotec to Buy GlaxoSmithKline's Italian R&D Facility
01.07.EVOTEC : creates long-term growth opportunities by initiating "Campus Levi-Montalcini" in ..
01.07.PRESS RELEASE : Evotec creates long-term growth opportunities by initiating 'Campus Levi-M..
01.07.EVOTEC : creates long-term growth opportunities by initiating 'Campus Levi-Montalcini' in ..
01.07.Evotec SE acquired Campus Levi-Montalcini from GlaxoSmithKline plc.
30.06.EVOTEC SE : Release according to Article 41 of the WpHG [the German Securities Trading Act..
1  2  3  4  5  6  7  8  9  10Weiter